InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: homebuilder_watcher post# 4240

Monday, 04/15/2013 10:43:35 AM

Monday, April 15, 2013 10:43:35 AM

Post# of 425975
I'm with you on I expected to be long out of the stock but also knew the potential longer term in case BO did not happen. I do believe if NCE was granted quickly they would have sold the company right after
I don't think Anchor approval is moving the price for several reasons
1) It's 6-8 months away and investors have time and put money to work elsewhere for now
2) The company cannot launch ANCHOR on it's own so WS is waiting to see if dilution will occur or what type of partnership deal
3)There is still the FDA acceptance that needs to come by Mid-May, until then Anchor timeline still up in the air and no reason to invest for Anchor before then
4) Several Bio stocks launched and had poor ramp up to sales, bio stocks launching new drugs are strongly in the SHOW US you can do it stage for WS.

It was posted on several blogs and boards that IF there was no BO the stock would go to 8(according to some large investors) so I knew where it would be at with no BO but AMRN has a long story to play out. 2014 is HUGE, no Lovaza generic in marine for full year, Should be Tier 2 everywhere, in Anchor no competition.
How they go about getting Anchor launched is the key to the company, if they fail that then REDUCE IT can still save them but ANCHOR or bust for longs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News